Literature DB >> 21259007

Polyarteritis nodosa and Henoch-Schönlein purpura nephritis in a child with familial Mediterranean fever: a case report.

Ilknur Girisgen1, Ferah Sonmez, Kutsi Koseoglu, Seda Erisen, Dilek Yilmaz.   

Abstract

Familial Mediterranean fever is an autosomal recessive disease characterized by recurrent self-limited attacks of fever accompanied by peritonitis, pleuritis, and arthritis. Approximately 5% of individuals with familial Mediterranean fever have been reported to have Henoch-Schonlein purpura and about 1% to have polyarteritis nodosa. A 7-year-old girl presenting with complaints of purpuric rash, abdominal pain, arthritis, hematuria, and proteinuria and having IgA depositions on renal biopsy was diagnosed as Henoch-Schönlein nephritis. She had a history of recurrent fever, abdominal and joint pain and M694 V compound homozygote mutation. Colchicine treatment was started for the diagnosis of FMF. When constitutional symptoms such as myalgia, weight loss, fatigue, fever, and hypertension were added to the clinical picture, the diagnosis of polyarteritis nodosa HSP was thought and confirmed by the demonstration of microaneurisms on renal arteries. There was no response to corticosteroid and cyclophosphamide treatments; however, the symptoms were rapidly and dramatically reduced after the administration of intravenous immunoglobulin. In conclusion, polyarteritis nodosa and Henoch-Schonlein purpura can be seen together with familial Mediterranean fever. It is also suggested that IVIG might be an important adjunct therapy in selected patients with polyarteritis nodosa, especially in the lack of response to steroids and immunsuppressive drugs.

Entities:  

Mesh:

Year:  2011        PMID: 21259007     DOI: 10.1007/s00296-010-1766-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  25 in total

1.  Clinical, laboratory and molecular characteristics of children with Familial Mediterranean Fever-associated vasculitis.

Authors:  M Tekin; F Yalçinkaya; N Tümer; N Akar; M Misirlioğlu; N Cakar
Journal:  Acta Paediatr       Date:  2000-02       Impact factor: 2.299

Review 2.  Familial Mediterranean fever. A survey of 470 cases and review of the literature.

Authors:  E Sohar; J Gafni; M Pras; H Heller
Journal:  Am J Med       Date:  1967-08       Impact factor: 4.965

3.  Mutation frequency of Familial Mediterranean Fever and evidence for a high carrier rate in the Turkish population.

Authors:  E Yilmaz; S Ozen; B Balci; A Duzova; R Topaloglu; N Besbas; U Saatci; A Bakkaloglu; M Ozguc
Journal:  Eur J Hum Genet       Date:  2001-07       Impact factor: 4.246

4.  Clinical quiz: a pediatric case presenting with fever and diffuse myalgia.

Authors:  Alper Soylu; Yeşim Oztürk; Belde Kasap; Nilüfer Akman; Mehmet Türkmen; Salih Kavukçu
Journal:  Rheumatol Int       Date:  2004-11-10       Impact factor: 2.631

5.  Cerebral vasculitis in a child with Henoch-Schönlein purpura and familial Mediterranean fever.

Authors:  Ozan Ozkaya; Kenan Bek; Neşe Alaca; Meltem Ceyhan; Yonca Açikgöz; Haydar Ali Taşdemir
Journal:  Clin Rheumatol       Date:  2007-01-19       Impact factor: 2.980

6.  EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria.

Authors:  Seza Ozen; Angela Pistorio; Silvia M Iusan; Aysin Bakkaloglu; Troels Herlin; Riva Brik; Antonella Buoncompagni; Calin Lazar; Ilmay Bilge; Yosef Uziel; Donato Rigante; Luca Cantarini; Maria Odete Hilario; Clovis A Silva; Mauricio Alegria; Ximena Norambuena; Alexandre Belot; Yackov Berkun; Amparo Ibanez Estrella; Alma Nunzia Olivieri; Maria Giannina Alpigiani; Ingrida Rumba; Flavio Sztajnbok; Lana Tambic-Bukovac; Luciana Breda; Sulaiman Al-Mayouf; Dimitrina Mihaylova; Vyacheslav Chasnyk; Claudia Sengler; Maria Klein-Gitelman; Djamal Djeddi; Laura Nuno; Chris Pruunsild; Jurgen Brunner; Anuela Kondi; Karaman Pagava; Silvia Pederzoli; Alberto Martini; Nicolino Ruperto
Journal:  Ann Rheum Dis       Date:  2010-05       Impact factor: 19.103

7.  Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa.

Authors:  Fatoş Yalçinkaya; Z Birsin Ozçakar; Ozgür Kasapçopur; Ayşenur Oztürk; Nejat Akar; Ayşin Bakkaloğlu; Nil Arisoy; Mesiha Ekim; Seza Ozen
Journal:  J Pediatr       Date:  2007-08-28       Impact factor: 4.406

8.  Vasculitis in siblings with familial Mediterranean fever: a report of three cases and review of the literature.

Authors:  Alexandra Balbir-Gurman; Abraham Menahem Nahir; Yolanda Braun-Moscovici
Journal:  Clin Rheumatol       Date:  2006-07-06       Impact factor: 3.650

9.  Polyarteritis nodosa in a case of familial Mediterranean fever.

Authors:  Sevcan A Bakkaloğlu; Sule Muzaç; Sergin Akpek; Oğuz Söylemezoğlu; Necla Buyan; Enver Hasanoğlu
Journal:  Pediatr Nephrol       Date:  2004-02-12       Impact factor: 3.651

10.  Rapidly progressive glomerulonephritis in a child with Henoch-Schönlein Vasculitis and familial Mediterranean fever.

Authors:  Betul Sozeri; Sevgi Mir; Pelin Ertan; Orhan Deniz Kara; Sait Sen
Journal:  Pediatr Rheumatol Online J       Date:  2009-05-07       Impact factor: 3.054

View more
  4 in total

Review 1.  Cardiovascular disease in patients with autoinflammatory syndromes.

Authors:  Rainer Hintenberger; Agnes Falkinger; Kathrin Danninger; Herwig Pieringer
Journal:  Rheumatol Int       Date:  2017-11-01       Impact factor: 2.631

2.  Intravenous immunoglobulin therapy in vasculitic ulcers: a case of polyarteritis nodosa.

Authors:  Petra M Pego; Inês Aguiar Câmara; José Pedro Andrade; João Matos Costa
Journal:  Auto Immun Highlights       Date:  2013-02-27

3.  Association of Vasculitis and Familial Mediterranean Fever.

Authors:  Salam Abbara; Gilles Grateau; Stéphanie Ducharme-Bénard; David Saadoun; Sophie Georgin-Lavialle
Journal:  Front Immunol       Date:  2019-04-12       Impact factor: 7.561

4.  Recurrent Macroscopic Hematuria and Abdominal Pain: Questions and Answers.

Authors:  Azar Nickavar
Journal:  Iran J Public Health       Date:  2015-08       Impact factor: 1.429

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.